Evelyn Partners Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.9K Sell
187
-2,577
-93% -$1.4M 0.02% 139
2025
Q4
$1.6M Buy
2,764
+52
+2% +$29.4K 0.38% 58
2025
Q3
$1.32M Buy
2,712
+101
+4% +$47K 0.3% 58
2025
Q2
$1.06M Buy
2,611
+393
+18% +$164K 0.27% 58
2025
Q1
$1.1M Sell
2,218
-1,198
-35% -$649K 0.31% 56
2024
Q4
$1.78M Buy
+3,416
New +$1.88M 0.48% 49

Other funds holding TMO

Evelyn Partners Asset Management's TMO Position: Q1 2026 in Review

Evelyn Partners Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 93% in Q1 2026, selling an estimated $1.4M and leaving 187 shares worth $91.9K. The position accounts for 0.02% of the portfolio, ranked #139.

Evelyn Partners Asset Management first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.78M in Q4 2024. 2,602 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Evelyn Partners Asset Management held 187 shares of Thermo Fisher Scientific worth $91.9K as of Q1 2026.
  • Evelyn Partners Asset Management sold 2,577 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.4M.
  • Thermo Fisher Scientific made up 0.02% of Evelyn Partners Asset Management's portfolio in Q1 2026, its #139 holding.
  • Evelyn Partners Asset Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Asset Management's Thermo Fisher Scientific position peaked at $1.78M in Q4 2024.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Evelyn Partners Asset Management's 13F filing for Q1 2026, filed 15 May 2026.